Respiratory Syncytial Virus News and Research

RSS

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

A recent paper examines the occurrence of other respiratory viral infections during this period in patients already infected with SARS-CoV-2.

29 Mar 2022

Understanding how coronavirus, RS virus and rhinovirus affect children

When Inger Heimdal started studying the coronavirus in children in 2014, not many people thought the topic sounded particularly exciting.

18 Mar 2022

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Researchers assessed the role of hypoxia-inducible factors in SARS-CoV-2 infection, respiratory symptoms, and epithelial damage.

18 Mar 2022

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Researchers conducted a prospective household cohort study of COVID-19, influenza, and respiratory syncytial virus community burden, viral interaction, and transmission dynamics, called PHIRST-C study in South Africa.

18 Mar 2022

COVID-19-related hospitalization among infants and young children in the US

Researchers investigated COVID-19-associated hospitalization among children and infants aged zero to four years in the United States during March 2020 and February 2022.

18 Mar 2022

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

A new study discussed the impact of COVID-19 measures on the future transmission of the respiratory syncytial virus in South Africa.

17 Mar 2022

Antimicrobial prescribing among infants may be prevented using maternal RSV vaccines

RSV is a leading cause of severe acute lower respiratory tract infections (LRTIs) among infants globally, and a prominent contributor to common non-severe infections that account for high volumes of antibiotic consumption.

14 Mar 2022

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

The new drug nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled phase 3 clinical trial published in the New England Journal of Medicine.

9 Mar 2022

Virginia Tech-led researchers to investigate the transmission of flu in child care settings

In January, the Centers for Disease Control and Prevention (CDC) updated its guidance for reducing SARS-CoV-2 (COVID-19) transmission in schools and day care settings.

6 Mar 2022

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Scientists have recently revealed that memory T cell responses to common cold coronaviruses stably persist for a long time.

4 Mar 2022

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled Phase 3 clinical trial.

3 Mar 2022

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Antibiotics provide no benefit in preventing future recurrent wheezing in babies hospitalized with respiratory syncytial virus (RSV), according to a new study led by Washington University School of Medicine in St. Louis. And there is some evidence that antibiotics may make wheezing worse.

27 Feb 2022

Respiratory Syncytial Virus News and Research

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Understanding how coronavirus, RS virus and rhinovirus affect children

Hypoxia-inducible factors and SARS-CoV-2 manifestations

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

COVID-19-related hospitalization among infants and young children in the US

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

Antimicrobial prescribing among infants may be prevented using maternal RSV vaccines

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

Virginia Tech-led researchers to investigate the transmission of flu in child care settings

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

Human nose organoids provide better understanding of the first steps toward SARS-CoV-2 infection

South African population reveal durable protection by prior infection against pre-Omicron variants

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

In super-vaxxed Vermont, covid strikes — but packs far less punch

Study demonstrates differential alternative splicing in betacoronaviruses

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News